Investigational RSV and hMPV Vaccine Study

Now Enrolling Adults Ages 18 to 49 and/or 60 and Older

Now Enrolling

About this research study

Respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) are common viruses that can cause respiratory infections, especially in infants, children, seniors and immunocompromised people. Velocity is conducting a clinical trial for a combined investigational mRNA vaccine for RSV and hMPV for adults.

Eligible participants...

  • Must be 18 to 49 and/or 60 and Older
  • Must NOT have a known history of RSV or hMPV associated illness within the past 12 months
  • Must NOT have previously received vaccination against RSV and/or hMPV with an investigational or licensed vaccine
  • Must NOT have received any mRNA vaccine or product within the past 2 months
  • Must NOT have received any other, non mRNA vaccines within the past 4 weeks
  • Will receive compensation for study-related time
  • Do not need insurance to join this study

For more information, complete the form on this page. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.

Enter your info

This field is for validation purposes and should be left unchanged.
Name(Required)
Date of birth(Required)
Age can help us determine study eligibility (you must be age 18 or older to submit this form).
Race(Required)
Select one or more designations that best describe you. This information can help Velocity better ensure all populations are represented in research.
This field is hidden when viewing the form

By entering your email address and/or phone number on this form, you represent that you are at least 18 years of age and you consent to receiving telephone calls and/or emails from Velocity Clinical Research or a third party on behalf of Velocity Clinical Research. For any help regarding messaging, please email us at [email protected]. For full details, refer to Velocity's privacy policy and website terms of use. Submissions on this website are not monitored 24/7. Do NOT submit personal health or medical information on this form. If you are enrolled in a trial and have questions, please call your research site.

Study Locations

Binghamton, New York • Velocity Clinical Research

1130 Upper Front St., Binghamton, NY 13905
Phone: (607) 800-5777

Boise (Meridian), Idaho • Velocity Clinical Research

2950 E. Magic View Dr., Suite 100, Meridian, ID 83642
Phone: (208) 377-8653

Cleveland, Ohio • Velocity Clinical Research

3619 Park East Dr., Suite 300, Beachwood, OH 44122
Phone: (216) 682-0320

Gardena, California • Velocity Clinical Research

1141 W. Redondo Beach Blvd., Suite 308, Gardena, CA 90247
Phone: (424) 551-7316

Hallandale Beach, Florida • Velocity Clinical Research

911 E Hallandale Beach Blvd, Hallandale Beach, FL 33009
Phone: (954) 455-5757

New Orleans, Louisiana • Velocity Clinical Research

3308 Tulane Ave., Suite 600, New Orleans, LA 70119
Phone: (504) 304-7197

Sioux City, Iowa • Velocity Clinical Research

4802 Sunnybrook Drive, Sioux City, IA 51106
Phone: (712) 639-6300
Row concave Shape Decorative svg added to top

©2023 Velocity Clinical Research | All Rights Reserved | Privacy Policy